Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against

Candida PK/PD analysis antifungal drugs dose optimization liposomal amphotericin B pharmacodynamics

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
03 Jul 2024
Historique:
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: aheadofprint

Résumé

As comparative pharmacokinetic/pharmacodynamic (PK/PD) studies of liposomal amphotericin B (L-AMB) against

Identifiants

DOI: 10.1128/aac.00225-24 PMID: 38958455
pubmed: 38958455
doi: 10.1128/aac.00225-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0022524

Auteurs

Maria-Ioanna Beredaki (M-I)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, NKUA, Athens, Greece.

Maiken C Arendrup (MC)

Unit of Mycology, Department of Microbiological Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
Department of Clinical Microbiology, University Hospital Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID: 0000-0002-4747-0144

Spyros Pournaras (S)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, NKUA, Athens, Greece.

Joseph Meletiadis (J)

Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, NKUA, Athens, Greece.
ORCID: 0000-0002-8869-1509

Classifications MeSH